Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Scilipoti

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Prostate Cancer and Prostatic Diseases|May 2, 2026
Clinical and surgical management of recto-urinary fistula after radical prostatectomy: a systematic review on current evidenceMario de Angelis, Pietro Scilipoti, Riccardo Leni, et al.
European Urology Oncology|June 20, 2024
The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPietro Scilipoti, Aleksander Ślusarczyk, Mario de Angelis, et al.
European Urology Oncology|April 9, 2025
Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future PerspectivesMattia Longoni, Pietro Scilipoti, Francesco Soria, et al.
European Urology Focus|April 29, 2025
The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired AnalysisNikolaos Pyrgidis, Gerald Bastian Schulz, Pietro Scilipoti, et al.
European Urology Oncology|May 12, 2026
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPaolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International|March 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-upRoberto Contieri, Alberto Martini, Marc Furrer, et al.
European Urology Oncology|January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission TomographyGiorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Prostate Cancer and Prostatic Diseases|May 2, 2026
Clinical and surgical management of recto-urinary fistula after radical prostatectomy: a systematic review on current evidenceMario de Angelis, Pietro Scilipoti, Riccardo Leni, et al.
European Urology Oncology|June 20, 2024
The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPietro Scilipoti, Aleksander Ślusarczyk, Mario de Angelis, et al.
European Urology Oncology|April 9, 2025
Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future PerspectivesMattia Longoni, Pietro Scilipoti, Francesco Soria, et al.
European Urology Focus|April 29, 2025
The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired AnalysisNikolaos Pyrgidis, Gerald Bastian Schulz, Pietro Scilipoti, et al.
European Urology Oncology|May 12, 2026
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPaolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International|March 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-upRoberto Contieri, Alberto Martini, Marc Furrer, et al.
European Urology Oncology|January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission TomographyGiorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
Pageof 10